2Cole SPC, Bhardwa JG, Gerlach JH, et al. Overexpression of transporter gene in a mulfidrug-resistant human lung cancer cell line.Science, 1992, 258 : 1650-1654.
3Bradshaw DM, Arceci BJ. Clinical relevance of transmembrane drug efflux as a mechanism of multidrug resistance. J Clin Oncol, 1998,16 : 3674 -3690.
4Breunlnger LM, Paul S, Gaughan K, et al. Expression of multidrug resistance-associated protein in NIH/3T3 cells coders muhidrug resistance associated with increased drug etllux and altered intracellular drug distribution. Cancer Res, 1995, 55:5342-5347.
5Hipfner DR, Deeley RG, Coloe SP. Structural, mechanistic and clinical aspects of MRPI. Biochim Biophys Acta, 1999, 1461:359-376.
6Sczakiel G. The design of antisense RNA. Antisense Nucleic Acid Drug Dev, 1997, 7:439-444.
7Richert ND, Aldwin L, Nitesci D, et al. Stability and covalent modification of P-glycoprotein in multidrug resistance KB cells.Biochemistry, 1988, 27:760.
